Skip to main content

Genus

Genus plc is a British animal genetics biotechnology company delivering elite breeding technology to the global livestock industry. The company uses biotechnology and genomic selection to breed elite pigs under the PIC brand and dairy and beef cattle under the ABS brand, alongside offering bovine artificial insemination and sexed semen technology. Main revenue drivers include commercial sales of elite breeding pigs, bovine semen straws, embryo transfer services, and gene-editing royalty agreements. Genus serves commercial pork producers, dairy farmers, and beef cattle breeders across North America, Latin America, Europe, and Asia. The company holds a world-dominant market position in porcine and bovine genetics and livestock breeding technology. Headquartered in Basingstoke, United Kingdom, Genus plc is listed on the London Stock Exchange.

7 of the funds FundTelligence covers report a position in Genus.

Legal name
Genus PLC
Sector
Health Care
Country
United Kingdom
Funds holding it
7
Exposure themes
Agricultural Technology & Inputs, Food & Agriculture Transformation, Inputs & Biologicals

Funds holding Genus

Loading...